| Current Price | $4.52 | Mkt Cap | $174.3M |
|---|---|---|---|
| Open | $4.38 | P/E Ratio | 0.00 |
| Prev. Close | $4.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.38 - $4.65 | Volume | 443,010 |
| 52-Wk Range | $3.74 - $31.54 | Avg. Daily Vol. | 695,918 |
| Current Price | $4.52 | Mkt Cap | $174.3M |
|---|---|---|---|
| Open | $4.38 | P/E Ratio | 0.00 |
| Prev. Close | $4.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.38 - $4.65 | Volume | 443,010 |
| 52-Wk Range | $3.74 - $31.54 | Avg. Daily Vol. | 695,918 |
The best Bull and Bear pitches based on recency and number of recommendations.
ORMP has been rivetingly focused over the last decade on solving one of the holy grail dreams of diabetic medicine - the discovery of a safe, consistent oral insulin pill which will end the use of injectables. They are suddenly getting close. In… More
With less than 10m in cash and no candidate in phase 3, ORMP's hype can't last long. The market cap should be back down to 100M. Just my 2 cents
Read the most recent pitches from players about ORMP.
Recs
krsjuls911
(< 20)
Submitted: 8/10/2021 8:15:02 AM :
Start Price:
$23.30
NASDAQ:ORMP Score:
-68.57
Oral insulin
Recs
NHWeston102
(64.17)
Submitted: 3/22/2021 11:33:07 AM :
Start Price:
$10.08
NASDAQ:ORMP Score:
-54.36
ORMP has been rivetingly focused over the last decade on solving one of the holy grail dreams of diabetic medicine - the discovery of a safe, consistent oral insulin pill which will end the use of injectables. They are suddenly getting close. In addition, ORMP has an obesity treatment in the works. They are also partnering on a COVID vaccine, assuming (quite reasonably) that COVID, like the Flu (inFLUenza", remember?), require a seasonal "booster" long after the pandemic has subsided. They will eventually succeed, diabetics will be liberated from needle doses and all their complications, and ORMP will either make a barrel of profits or a company like Novo-Nordisk or Lilly will buy them up.
Recs
JB3NC
(< 20)
Submitted: 7/22/2020 1:26:09 PM :
Start Price:
$3.87
NASDAQ:ORMP Score:
-3.91
Is in phase 3 testing of a oral insulin drug. I hate shots.
Find the members with the highest scoring picks in ORMP.
midastouch017 (< 20) Score: +211.23
The Score Leader is the player with the highest score across all their picks in ORMP.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| kevrose31 | 77.39 | 1/10/2014 |
|
1Y | $24.39 | -81.47% | +111.68% | +193.14 | 0 Comment | |
| GabrielSevrs | 35.47 | 6/8/2021 |
|
3W | $13.62 | -66.81% | -7.84% | +58.97 | 0 Comment | |
| Flashvictor | < 20 | 7/16/2020 |
|
5Y | $3.52 | +28.41% | +21.76% | +6.65 | 0 Comment | |
| retiren20 | < 20 | 7/30/2020 |
|
1Y | $3.77 | +19.89% | +20.96% | -1.07 | 0 Comment | |
| JB3NC | < 20 | 7/28/2020 |
|
5Y | $3.87 | +16.95% | +20.85% | -3.91 | 3 Comments | |
| naylorj | 68.49 | 1/26/2021 |
|
1Y | $5.80 | -22.07% | +1.03% | -23.10 | 0 Comment | |
| Eskilf | 70.46 | 2/4/2020 |
|
5Y | $5.09 | -11.20% | +18.07% | -29.27 | 0 Comment | |
| DavidSobel | < 20 | 4/22/2021 |
|
5Y | $8.50 | -46.82% | -6.37% | -40.45 | 0 Comment | |
| VetteNV | < 20 | 2/2/2021 |
|
3Y | $7.78 | -41.90% | +2.56% | -44.47 | 0 Comment | |
| theblindhog | 23.69 | 3/26/2021 |
|
1Y | $9.94 | -54.53% | -0.40% | -54.13 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
